Gsk Plc · LSE:GSK

Gsk — GlaxoSmithKline Consumer Healthcare — Q2 FY19-20 Earnings Presentation

5 slides from Gsk's earnings presentation, 2019

Slide 1: GlaxoSmithKline Consumer Healthcare Limited Financial Results Q2 FY19-20
GlaxoSmithKline Consumer Healthcare Limited Financial Results Q2 FY19-20
Slide 2: Quarter Highlights
Quarter Highlights Revenue increased by 6% with Domestic growth of 7% PBT increased by 6% Continued investment behind brands: 11% vs LY to fund innovation & drive Horlicks Campaign Drive HFD Consumption Brand building initiatives, continue to strengthen / expand the initiatives: • ‘Hunger for Growth
Slide 3: Financial Performance: Q2 FY19-20
Financial Performance: Q2 FY19-20 In Cr Particulars Q2 FY19-20 Q2 FY 18-19 Growth % Revenue from Operations 1,345 1,272 6% EBITDA 403 378 7% PBT 452 427 6% PAT 345 275 25%
Slide 4: Market Share
Market Share Brand Volume Value Horlicks 50.4% Horlicks 43.7% Boost 15.2 % Boost 11.4 % Horlicks continues to be at first position in HFD category Source – AC Nielsen; Market Share L3M September 19
Slide 5: Thank You
Thank You